It’s the insulin, stupid: How drug pricing’s simplest case study became a top issue for 2020 Democrats
(By Lev Facher for STAT) WATERLOO, Iowa — Presidential candidates can’t stop talking about insulin. At a campaign stop here
Read More
California Reopens The Single-Payer Debate
(By Rachel Bluth for Kaiser Health News) California Gov. Gavin Newsom was a single-payer candidate. The Democrat campaigned hard for
Read MoreSetting funds aside for healthcare
A new report by RxSaver by RetailMeNot estimated 31 percent of Americans have a health-related emergency fund and 47 percent
Read MoreImproving behaviors and sleep patterns in people with Alzheimer’s
Light therapy tailored to increase the circadian stimulation during the day benefited individuals with Alzheimer’s disease or dementia living in
Read MoreMedicare’s general enrollment period is still going until March 31st
Medicare provides critical health benefits to million of seniors. However, if you missed your chance to enroll during your initial
Read More4th patient charity settles Medicare kickback allegations
(By Maia Anderson for Becker’s Hospital Review) A fourth patient charity agreed to pay $3 million to settle claims it
Read More‘The time to worry is now’: The coronavirus in China could threaten pharma’s ingredient sourcing
(By Ed Silverman for STAT) As a novel coronavirus spreads through China and rattles the rest of the world, the
Read MorePrecautions are in place. Now U.S. hospitals and states ready for more cases of novel virus from China
(By Shraddha Chakradhar and Andrew Joseph for STAT) It seemed like it was only a matter of time. Even before
Read MoreCMS’ new Medicare Care Compare website
The Centers for Medicare and Medicaid Services (CMS) announced that it plans to combine and standardize its eight separate Compare
Read MoreWant to know how contentious drug pricing is in Washington? Check the receipts
(By Nicholas Florko for STAT) WASHINGTON — Pfizer, Johnson & Johnson, Merck, and the 31 other major drug makers that
Read More